In a filing, Teladoc Health Inc revealed its Chief Accounting Officer Catapano Joseph Ronald unloaded Company’s shares for reported $23434.0 on Oct 02 ’25. In the deal valued at $7.88 per share,2,972 shares were sold. As a result of this transaction, Catapano Joseph Ronald now holds 5,361 shares worth roughly $44871.56999999999.
Then, DIVITA CHARLES III sold 16,787 shares, generating $127,435 in total proceeds. Upon selling the shares at $7.59, the CHIEF EXECUTIVE OFFICER now owns 179,014 shares.
Before that, DIVITA CHARLES III bought 16,787 shares. Teladoc Health Inc shares valued at $127,435 were divested by the Officer at a price of $7.59 per share.
Mizuho initiated its Teladoc Health Inc [TDOC] rating to a Neutral in a research note published on July 25, 2025; the price target was $10. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Jefferies also remained covering TDOC and reiterated its “Hold” recommendation on September 17, 2024. Cantor Fitzgerald started covering the stock on February 29, 2024. It rated TDOC as “an Overweight”.
Price Performance Review of TDOC
On Tuesday, Teladoc Health Inc [NYSE:TDOC] saw its stock fall -2.33% to $8.37. Over the last five days, the stock has gained 8.28%. Teladoc Health Inc shares have fallen nearly -3.57% since the year began. Nevertheless, the stocks have fallen -7.92% over the past one year. While a 52-week high of $15.21 was reached on 02/14/25, a 52-week low of $6.35 was recorded on 04/21/25.
Levels Of Support And Resistance For TDOC Stock
The 24-hour chart illustrates a support level at 8.18, which if violated will result in even more drops to 8.00. On the upside, there is a resistance level at 8.59. A further resistance level may holdings at 8.82.
How much short interest is there in Teladoc Health Inc?
A steep rise in short interest was recorded in Teladoc Health Inc stocks on 2025-09-15, growing by 0.2 million shares to a total of 23.82 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 23.62 million shares. There was a rise of 0.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 26, 2024 when Leerink Partners began covering the stock and recommended ‘”a Market perform”‘ rating along with a $17 price target.
